Drug Profile


Alternative Names: CBS 113A; Icoduline

Latest Information Update: 21 May 1996

Price : $50

At a glance

  • Originator Chauvin
  • Class Analgesics; Anti-inflammatories; Antiallergics; Small molecules
  • Mechanism of Action 5-lipoxygenase inhibitors; Cyclooxygenase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Eye disorders; Skin disorders

Most Recent Events

  • 21 May 1996 Discontinued-III for Eye disorders in France (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top